Quantum Menstrual Health Monitoring Study

Launched by QUANOVATE TECH INC. · Jun 29, 2023

Keywords

ClinConnect Summary

The Quantum Menstrual Health Monitoring Study is researching how certain hormones in urine can help us understand menstrual cycles, especially in women with regular cycles, those with Polycystic Ovary Syndrome (PCOS), and female athletes. The study aims to find patterns that indicate when ovulation occurs, which is when a woman’s ovary releases an egg. By comparing hormone levels in urine with blood tests and ultrasounds, researchers hope to learn more about the menstrual cycle's normal and irregular patterns. This study is important because it may help improve understanding and treatment of menstrual cycle issues.

To participate, women aged 18 to 45 who have regular menstrual cycles, PCOS, or are athletes can apply. Participants must be willing to visit the Calgary Clinic for regular ultrasounds and should have knowledge of their last three cycle lengths. They need to have a negative pregnancy test at the start and end of each cycle, and their cycles should last between 24 to 34 days. However, certain conditions and medications can make someone ineligible to participate. Throughout the study, participants can expect to provide urine samples, have their hormone levels monitored, and track their menstrual cycle signs, such as bleeding and temperature, alongside their sleep patterns.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Regularly menstruating, PCOS or athlete participants aged 18-45
• • Negative pregnancy test at the beginning and at the end of each cycle
• • Cycle lengths 24-34 days
• • Knowledge of previous 3 cycle lengths
• • Able to travel to Calgary Clinic for regular ultrasounds during the study period
• Exclusion Criteria:
• • For regular cycles
• • Anovulation in the last 3 cycles
• • Currently or in the previous 3 months, on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, etc)
• • Known conditions that impair ovulation or fertility: polycystic ovarian syndrome, endometriosis, pelvic inflammatory disease in the last year, pituitary adenomas, exclusively breastfeeding
• • Previous surgeries impacting the menstrual cycle: hysterectomy, bilateral oophorectomy
• • Currently pregnant
• * For PCOS and athlete groups:
• • Currently or in the previous 3 months, on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, etc)
• • Known conditions that impair ovulation or fertility: pelvic inflammatory disease in the last year, pituitary adenomas, exclusive breastfeeding
• • Previous surgeries impacting the menstrual cycle: hysterectomy, bilateral oophorectomy
• • Currently pregnant